Co-occurring mutations in the POLE exonuclease and non-exonuclease domains define a unique subset of highly mutagenic tumors

Somatic POLE mutations in the exonuclease domain (ExoD) are prevalent in colorectal cancer (CRC), endometrial cancer (EC), and others and typically lead to dramatically increased tumor mutation burden (TMB). To understand whether non-ExoD mutations also play a role in mutagenesis, we assessed TMB in 447/14541 POLE-mutated CRCs, ECs, and ovarian cancers (OC) based on classification TMB-High (TMB-H) or TMB-Low (TMB-L). TMB-H tumors were segregated as ‘POLE ExoD driver’, ‘POLE ExoD driver plus POLE Variant’, and ‘POLE Variant TMB-H’. Intriguingly, TMB was highest in tumors bearing ‘POLE ExoD driver plus POLE Variant’ (p<0.001 in CRC and EC, p<0.05 in OC). Integrated analysis of AlphaFold2-modeled POLE models and quantitative estimate of stability indicated that multiple variants had significant impact on functionality. These data indicate that co-occurring POLE variants categorize a unique subset of POLE-driven tumors defined by ultra-high TMB, which has implications for abundance of tumor neoantigens, therapeutic response, and patient outcomes. Significance Somatic POLE ExoD driver mutations cause proofreading deficiency that induces high tumor mutation burden (TMB). This study defines a novel modifier role for non-ExoD mutations in POLE ExoD-driven tumors, associated with ultra-high TMB. These data may inform acquisition of tumor neoantigens, tumor classification, therapeutic response, and patient outcomes.

[1]  C. Tournigand,et al.  PD-1 blockade in solid tumors with defects in polymerase epsilon. , 2022, Cancer discovery.

[2]  J. Shen,et al.  Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers , 2022, JCO precision oncology.

[3]  Scott R. Kennedy,et al.  Probing the mechanisms of two exonuclease domain mutators of DNA polymerase ϵ. , 2022, Nucleic acids research.

[4]  Trevor J Pugh,et al.  Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency , 2022, Nature medicine.

[5]  M. Stratton,et al.  Increased somatic mutation burdens in normal human cells due to defective DNA polymerases , 2021, Nature Genetics.

[6]  K. Kavukcuoglu,et al.  Highly accurate protein structure prediction for the human proteome , 2021, Nature.

[7]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[8]  G. Getz,et al.  DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells. , 2020, Cancer discovery.

[9]  H. Okkels,et al.  New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients , 2020, Frontiers in Genetics.

[10]  T. Pons,et al.  Role of POLE and POLD1 in familial cancer , 2020, Genetics in Medicine.

[11]  R. Georgescu,et al.  Structure of the polymerase ε holoenzyme and atomic model of the leading strand replisome , 2020, Nature Communications.

[12]  Z. Pursell,et al.  POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status. , 2020, Molecular cell.

[13]  A. Spurdle,et al.  Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants , 2020, medRxiv.

[14]  A. Stenzinger,et al.  Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project , 2020, Journal for ImmunoTherapy of Cancer.

[15]  C. Gilks,et al.  Interpretation of somatic POLE mutations in endometrial carcinoma , 2019, The Journal of pathology.

[16]  Z. Pursell,et al.  POLE proofreading defects: Contributions to mutagenesis and cancer. , 2019, DNA repair.

[17]  M. Ebsen,et al.  POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma , 2019, Oncotarget.

[18]  Liping He,et al.  DeepDDG: Predicting the Stability Change of Protein Point Mutations Using Neural Networks , 2019, J. Chem. Inf. Model..

[19]  Sushma Sharma,et al.  A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme , 2019, Nature Communications.

[20]  S. C. Kamerlin,et al.  Structural consequence of the most frequently recurring cancer-associated substitution in DNA polymerase ε , 2019, Nature Communications.

[21]  C. Toulas,et al.  Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma , 2018, Familial Cancer.

[22]  C. Toulas,et al.  Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma , 2018, Familial Cancer.

[23]  H. Masuyama,et al.  Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability , 2018, PloS one.

[24]  K. Cole,et al.  Comprehensive Analysis of Hypermutation in Human Cancer , 2017, Cell.

[25]  T. Tahirov,et al.  Crystal structure of the human Polϵ B-subunit in complex with the C-terminal domain of the catalytic subunit , 2017, The Journal of Biological Chemistry.

[26]  Roland L. Dunbrack,et al.  The Rosetta all-atom energy function for macromolecular modeling and design , 2017, bioRxiv.

[27]  Sung‐Min Ahn,et al.  The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy , 2016, Oncotarget.

[28]  E. Golemis,et al.  POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies , 2016, Gene.

[29]  C. Lázaro,et al.  New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. , 2014, Human molecular genetics.

[30]  E. Johansson,et al.  Structural basis for processive DNA synthesis by yeast DNA polymerase ɛ , 2013, Nature Structural &Molecular Biology.

[31]  Peter Donnelly,et al.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.